Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Viral Molecular Diagnostics Market by Region & Data Validation, Analysis and Forecast 2022

Tuesday, February 21, 2017 11:01
% of readers think this story is Fact. Add your two cents.

(Before It's News)

According to Publisher, the Global Viral Molecular Diagnostics Market accounted for $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Growing incidence of viral diseases, rising aged population, technological advances in molecular diagnostics, increasing awareness about viral diseases and rising government initiatives in several regions are the key factors fueling the market growth. On the other hand, absence of skilled professionals and huge cost of molecular diagnostics are some of the key factors limiting the viral molecular diagnostics market growth.
North America is the major market for the viral molecular diagnostics followed by the Western Europe owing to growing number of key players within this market. Superior infrastructure and top awareness levels about various viral diseases among the people in these regions are the key factors attributed for their highest share. Asia-Pacific is the fastest growing market for various viral molecular diagnostic tests, owing to growing incidence of viral infections in this market.

 For more information http://www.reportsweb.com/viral-molecular-diagnostics-global-market-outlook-2015-2022

Some of the key players in the global viral molecular diagnostics market include Meridian Bioscience Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Thermo Fisher Scientific Corporation, BioMerieux SA, Auto Genomics Inc., Qiagen NV, Affymetrix Inc., Illumina Inc., Gen-Probe Inc., Roche Molecular Diagnostics, Siemens, Cepheid and Beckman Coulter.

Applications Covered:
- Respiratory Syncytial Virus
- Hepatitis
- AIDS
- Influenza
- Others
Technologies Covered:
- Real time PCR (RT-PCR) 
- Polymerase chain reaction (PCR) 
- Nucleic Acid Sequence Based Amplification 
- Other Molecular Diagnostic methods 
- Isothermal nucleic acid amplification technology (INAAT)
- Microarrays
- In situ hybridization
End User’s Covered:
- Academic Institutions 
- Hospitals 
- Ambulatory clinics 
- Diagnostic Laboratories
Products Covered: 
- Reagents
- Instrument
- Others

Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK 
- Spain 
- Rest of Europe 
- Asia Pacific
- Japan 
- China 
- India 
- Australia 
- New Zealand 
- Rest of Asia Pacific 
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt

Request Sample Copy http://www.reportsweb.com/inquiry&RW0001216337/sample

11 Company Profiling 
11.1 Meridian Bioscience Inc.
11.2 Becton Dickinson and Company
11.3 F. Hoffmann-La Roche Ltd.
11.4 Abbott Laboratories Inc.
11.5 Thermo Fisher Scientific Corporation 
11.6 BioMerieux SA
11.7 Auto Genomics Inc.
11.8 Qiagen NV
11.9 Affymetrix Inc.
11.10 Illumina Inc.
11.11 Gen-Probe Inc.
11.12 Roche Molecular Diagnostics
11.13 Siemens 
11.14 Cepheid 
11.15 Beckman Coulter

Make an enquiry: http://www.reportsweb.com/inquiry&RW0001216337/buying

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.